NCT02413450View on ClinicalTrials.gov

Derivation of Human Induced Pluripotent Stem (iPS) Cells to Heritable Cardiac Arrhythmias

Enrolling by invitationOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

August 31, 2030

Study Completion Date

August 31, 2031

Conditions
Inherited Cardiac ArrythmiasLong QT Syndrome (LQTS)Brugada Syndrome (BrS)Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)Early Repolarization Syndrome (ERS)Arrhythmogenic Cardiomyopathy (AC, ARVD/C)Hypertrophic Cardiomyopathy (HCM)Dilated Cardiomyopathy (DCM)Muscular Dystrophies (Duchenne, Becker, Myotonic Dystrophy)Normal Control Subjects
Trial Locations (1)

21287-9106

Johns Hopkins Medical Institute, Baltimore

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Johns Hopkins University

OTHER